Dutton Associates continues coverage of Neoprobe Corporation (OTCBB:
NEOP), maintaining its rating at Strong Speculative Buy with a higher
price target of $1.50. The...
Neoprobe Corporation (OTCBB:NEOP),
a diversified developer of innovative oncology and cardiovascular
surgical and diagnostic products, announced the extension of its
...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of Neoprobe Corporation (OTCBB:NEOP), upgrading its rating from Speculative Buy to Strong Speculative...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP) a diversified developer of innovative oncology diagnostic and treatment products and cardiovascular surgical and...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP) today announced financial results for the fourth quarter of 2006 and for the full year that ended December 31, 2006....
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced it...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative
oncology and cardiovascular surgical and diagnostic products, today
announced...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP),
a diversified developer of innovative oncology and cardiovascular
surgical and diagnostic products, announced today...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP),
a diversified developer of innovative oncology and cardiovascular
surgical and diagnostic products, today announced...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP),
a diversified developer of innovative oncology and cardiovascular
surgical and diagnostic products, today announced...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative
oncology and cardiovascular surgical and diagnostic products, today
announced...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative
oncology and cardiovascular surgical and diagnostic products, today
announced...
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative
oncology and cardiovascular surgical and diagnostic products, today
announced...